|
Yubo International Biotech Limited (MAGAA) |
|
Yubo International Biotech Limited
MAGAA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Yubo International Biotech Limited's sales fell
in IV. Quarter 2024 from the same quarter a year ago.
Medical Equipment & Supplies industry recorded
deterioration of revenues by -0.3 %
Yubo International Biotech Limited net loss decreased from $-1 millions, to $0 millions in IV. Quarter 2024,
• More on MAGAA's Growth
|
|
Yubo International Biotech Limited realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 158315.89 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 29929.46.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.07.
• More on MAGAA's Valuation
|
|
|
|
|
Yubo International Biotech Limited realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 158315.89 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 29929.46.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.07.
• More on MAGAA's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com